肠道菌群及免疫与胶质瘤关系的研究进展
Research Progress on the Relationship between Intestinal Flora, Immune System and Glioma
DOI: 10.12677/ACM.2021.1110638, PDF,   
作者: 潘灵峰, 茅 敏：青岛大学，山东 青岛；宫安静*：青岛大学附属医院神经外科，山东 青岛
关键词: 胶质瘤；肠道菌群；肠–脑轴；免疫；Glioma； Intestinal Flora； Gut-Brain Axis； Immune
摘要: 近年来，肠道菌群与人类疾病的关系研究日益深入，通过不断对肠道菌群的挖掘，发现肠道菌群与人体疾病的发生发展息息相关，并在疾病治疗中起重要作用。肠道菌群对中枢神经系统疾病起重要作用，肠道菌群的失调与阿尔茨海默病、癫痫、脱髓鞘等相关。肠道菌群在机体免疫成熟及调控中起重要作用。肠道菌群在胶质瘤中的研究已有所报道，然而，其与胶质瘤之间的具体关系尚未明确。本文将综述肠道菌群及免疫与胶质瘤之间的关系，为胶质瘤的治疗提供新思路。
Abstract: In recent years, the relationship between intestinal flora and human diseases has been further studied. Through continuous mining of intestinal flora, it has been found that intestinal flora is closely related to the occurrence and development of human diseases, and plays an important role in the treatment of diseases. Intestinal flora plays an important role in disease of central nervous system, and the disorder of intestinal flora is related to Alzheimer’s disease, epilepsy, demyelination and so on. Intestinal flora plays an important role in immune maturation and regulation. The intestinal flora has been reported in glioma; however, the specific relationship between intestinal flora and glioma remains unclear. This review will review the relationship between intestinal flora, immune system and glioma, and provide new ideas for the treatment of glioma.
文章引用：潘灵峰, 茅敏, 宫安静. 肠道菌群及免疫与胶质瘤关系的研究进展[J]. 临床医学进展, 2021, 11(10): 4357-4364. https://doi.org/10.12677/ACM.2021.1110638

参考文献

[1] Sundararajan, V., Bohensky, M.A., Moore, G., Brand, C.A., Lethborg, C., Gold, M., et al. (2014) Mapping the Patterns of Care, the Receipt of Palliative Care and the Site of Death for Patients with Malignant Glioma. Journal of Neuro-Oncology, 116, 119-126. [Google Scholar] [CrossRef] [PubMed]
[2] Claus, E.B., Walsh, K.M., Wiencke, J.K., Molinaro, A.M., Wiemels, J.L., Schildkraut, J.M., et al. (2015) Survival and Low-Grade Glioma: The Emergence of Genetic Information. Neurosurgical Focus, 38, Article No. E6. [Google Scholar] [CrossRef] 
[3] Zheng, H., Li, J., Shen, D., Yang, X., Zhao, S., Wu, Y., et al. (2015) BTG1 Expression Correlates with Pathogenesis, Aggressive Behaviors and Prognosis of Gastric Cancer: A Potential Target for Gene Therapy. Oncotarget, 6, 19685-19705. [Google Scholar] [CrossRef] [PubMed]
[4] 薛良军, 冯艳, 童文侠, 陈意红. 恶性胶质瘤术后辅助放疗同步替莫唑胺的临床观察[J]. 现代仪器与医疗, 2015, 21(4): 22-24.
[5] Park, C.K., Lee, S.H., Kim, T.M., Choi, S.H., Park, S.-H., Heo, D.S., et al. (2013) The Value of Temozolomide in Combination with Radiotherapy during Standard Treatment for Newly Diagnosed Glioblastoma. Journal of Neuro-Oncology, 112, 277-283. [Google Scholar] [CrossRef] [PubMed]
[6] van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., et al. (2013) Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile. New England Journal of Medicine, 368, 407-415. [Google Scholar] [CrossRef] 
[7] Guarino, A., Wudy, A., Basile, F., Ruberto, E. and Buccigrossi, V. (2012) Retraction: Composition and Roles of Intestinal Microbiota in Children. The Journal of Maternal-Fetal & Neonatal Medicine, 25, 63-66. [Google Scholar] [CrossRef] [PubMed]
[8] Compare, D., Coccoli, P., Rocco, A., Nardone, O.M., De Maria, S., Cartenì, M., et al. (2012) Gut-Liver Axis: The Impact of Gut Microbiota on Non Alcholic Fatty Liver Disease. Nutrition, Metabolism and Cardiovascular Diseases, 22, 471-476. [Google Scholar] [CrossRef] [PubMed]
[9] Hooper, L.V. and Gordon, J.I. (2001) Commensal Host-Bacterial Relationships in the Gut. Science, 292, 1115-1118. [Google Scholar] [CrossRef] [PubMed]
[10] Lynch, S.V. and Pedersen, O. (2016) The Human Intestinal Microbiome in Health and Disease. New England Journal of Medicine, 375, 2369-2379. [Google Scholar] [CrossRef] 
[11] Zhang, C., Zhang, M., Wang, S., Han, R., Cao, Y., Hua, W., et al. (2010) Interactions between Gut Microbiota, Host Genetics and Diet Relevant to Development of Metabolic Syndromes in Mice. The ISME Journal, 4, 232-241. [Google Scholar] [CrossRef] [PubMed]
[12] Maynard, C.L., Elson, C.O., Hatton, R.D. and Weaver, C.T. (2012) Reciprocal Interactions of the Intestinal Microbiota and Immune System. Nature, 489, 231-241. [Google Scholar] [CrossRef] [PubMed]
[13] Lamouse-Smith, E.S., Tzeng, A. and Starnbach, M.N. (2011) The Intestinal Flora Is Required to Support Antibody Responses to Systemic Immunization in Infant and Germ Free Mice. PLoS ONE, 6, Article ID: e27662. [Google Scholar] [CrossRef] [PubMed]
[14] Brandtzaeg, P. (2010) Function of Mucosa-Associated Lymphoid Tissue in Antibody Formation. Immunological Investigations, 39, 303-355. [Google Scholar] [CrossRef] [PubMed]
[15] Fulde, M. and Hornef, M.W. (2014) Maturation of the Enteric Mucosal Innate Immune System during the Postnatal Period. Immunological Reviews, 260, 21-34. [Google Scholar] [CrossRef] [PubMed]
[16] 高琰宇, 毕文静, 吴新颜, 等. 细菌耐药影响肠道菌群及机体免疫表达[J]. 生物工程学报, 2018, 34(8): 1259-1269.
[17] Wang, G., Huang, S., Wang, Y., Cai, S., Yu, H., Liu, H., et al. (2019) Bridging Intestinal Immunity and Gut Microbiota by Metabolites. Cellular and Molecular Life Sciences, 76, 3917-3937. [Google Scholar] [CrossRef] [PubMed]
[18] Westfall, S., Caracci, F., Zhao, D., Wu, Q.-L., Frolinger, T., Simon, J., et al. (2021) Microbiota Metabolites Modulate the T Helper 17 to Regulatory T Cell (Th17/Treg) Imbalance Promoting Resilience to Stress-Induced Anxiety- and Depressive-Like Behaviors. Brain, Behavior, and Immunity, 91, 350-368. [Google Scholar] [CrossRef] [PubMed]
[19] Noguera, R., Burgos-Panadero, R., Gamero-Sandemetrio, E., de la Cruz-Merino, L. and Álvaro Naranjo, T. (2019) An Integral View of Cancer (II). Fields of Investigation and Emerging Biomarkers. Revista Española de Patología, 52, 222-233. [Google Scholar] [CrossRef] [PubMed]
[20] Pradere, J.P., Dapito, D.H. and Schwabe, R.F. (2014) The Yin and Yang of Toll-Like Receptors in Cancer. Oncogene, 33, 3485-3495. [Google Scholar] [CrossRef] [PubMed]
[21] Wallace, B.D., Roberts, A.B., Pollet, R.M., Ingle, J.D., Biernat, K.A., Pellock, S.J., et al. (2015) Structure and Inhibition of Microbiome Beta-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity. Chemical Biology, 22, 1238-1249. [Google Scholar] [CrossRef] [PubMed]
[22] Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V. et al. (2018) Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Science, 359, 97-103. [Google Scholar] [CrossRef] [PubMed]
[23] Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., et al. (2018) The Commensal Microbiome Is Associated with Anti-PD-1 Efficacy in Metastatic Melanoma Patients. Science, 359, 104-108. [Google Scholar] [CrossRef] [PubMed]
[24] Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillère, R., et al. (2018) Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy against Epithelial Tumors. Science, 359, 91-97. [Google Scholar] [CrossRef] [PubMed]
[25] Rajagopala, S.V., Vashee, S., Oldfield, L.M., Suzuki, Y., Craig Venter, J., Telenti, A., et al. (2017) The Human Microbiome and Cancer. Cancer Prevention Research, 10, 226-234. [Google Scholar] [CrossRef] 
[26] Rothhammer, V., Mascanfroni, I.D., Bunse, L., Takenaka, M.C, Kenison, J.E., Mayo, L., et al. (2016) Type I Interferons and Microbial Metabolites of Tryptophan Modulate Astrocyte Activity and Central Nervous System Inflammation via the Aryl Hydrocarbon Receptor. Nature Medicine, 22, 586-597. [Google Scholar] [CrossRef] [PubMed]
[27] Cryan, J.F., O’Riordan, K.J., Cowan, C., Sandhu, K.V., Bastiaanssen, T.F.S., Boehme, M., et al. (2019) The Microbiota-Gut-Brain Axis. Physiological Reviews, 99, 1877-2013. [Google Scholar] [CrossRef] [PubMed]
[28] Stanley, D., Moore, R.J. and Wong, C. (2018) An Insight into Intestinal Mucosal Microbiota Disruption after Stroke. Scientific Reports, 8, Article No. 568. [Google Scholar] [CrossRef] [PubMed]
[29] Li, N., Wang, X., Sun, C., Wu, X., Lu, M., Si, Y., et al. (2019) Change of Intestinal Microbiota in Cerebral Ischemic Stroke Patients. BMC Microbiology, 19, Article No. 191. [Google Scholar] [CrossRef] [PubMed]
[30] Jangi, S., Gandhi, R., Cox, L.M., Li, N., von Glehn, F., Yan, R., et al. (2016) Alterations of the Human Gut Microbiome in Multiple Sclerosis. Nature Communications, 7, Article No. 12015. [Google Scholar] [CrossRef] [PubMed]
[31] Unger, M.M., Spiegel, J., Dillmann, K.U., Grundmann, D., Philippeit, H., Bürmann, J., et al. (2016) Short Chain Fatty Acids and Gut Microbiota Differ between Patients with Parkinson’s Disease and Age-Matched Controls. Parkinsonism & Related Disorders, 32, 66-72. [Google Scholar] [CrossRef] [PubMed]
[32] Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., et al. (2019) Potential Roles of Gut Microbiome and Metabolites in Modulating ALS in Mice. Nature, 572, 474-480. [Google Scholar] [CrossRef] [PubMed]
[33] Spor, A., Koren, O. and Ley, R. (2011) Unravelling the Effects of the Environment and Host Genotype on the Gut Microbiome. Nature Reviews Microbiology, 9, 279-290. [Google Scholar] [CrossRef] [PubMed]
[34] Rhee, S.H., Pothoulakis, C. and Mayer, E.A. (2009) Principles and Clinical Implications of the Brain-Gut-Enteric Microbiota Axis. Nature Reviews Gastroenterology & Hepatology, 6, 306-314. [Google Scholar] [CrossRef] [PubMed]
[35] 贺欣, 路瑶, 张目涵, 冯百岁. 神经调节在炎症性肠病中的作用和治疗进展[J]. 医学综述, 2017, 23(16): 3126-3131, 3136. [Google Scholar] [CrossRef] 
[36] 田祖宏, 聂勇战. 肠道微生物与脑-肠轴交互作用的研究进展[J]. 传染病信息, 2016, 29(5): 302-307.
[37] Berer, K., Mues, M., Koutrolos, M., Al Rasbi, Z., Boziki, M., Johner, C., et al. (2011) Commensal Microbiota and Myelin Autoantigen Cooperate to Trigger Autoimmune Demyelination. Nature, 479, 538-541. [Google Scholar] [CrossRef] [PubMed]
[38] Berer, K., Gerdes, L.A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., et al. (2017) Gut Microbiota from Multiple Sclerosis Patients Enables Spontaneous Autoimmune Encephalomyelitis in Mice. Proceedings of the National Academy of Sciences of the United States of America, 114, 10719-10724. [Google Scholar] [CrossRef] [PubMed]
[39] Cekanaviciute, E., Yoo, B.B., Runia, T.F., Debelius, J.W., Singh, S., Nelson, C.A., et al. (2017) Gut Bacteria from Multiple Sclerosis Patients Modulate Human T Cells and exacerbate Symptoms in Mouse Models. Proceedings of the National Academy of Sciences of the United States of America, 114, 10713-10718. [Google Scholar] [CrossRef] [PubMed]
[40] Quintana, F.J. and Prinz, M. (2017) A Gut Feeling about Multiple Sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 114, 10528-10529. [Google Scholar] [CrossRef] [PubMed]
[41] Rojas, O.L., Probstel, A.K., Porfilio, E.A., Wang, A.A., Charabati, M., Sun, T., et al. (2019) Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell, 176, 610-624. [Google Scholar] [CrossRef] [PubMed]
[42] Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., et al. (2014) The Gut Microbiota Influences Blood-Brain Barrier Permeability in Mice. Science Translational Medicine, 6, Article No. 263ra158. [Google Scholar] [CrossRef] [PubMed]
[43] Ben-Shaanan, T.L., Schiller, M., Azulay-Debby, H., Korin, B., Boshnak, N., Koren, T., et al. (2018) Modulation of Anti-Tumor Immunity by the Brain’s Reward System. Nature Communications, 9, Article No. 2723. [Google Scholar] [CrossRef] [PubMed]
[44] Engelhardt, B., Vajkoczy, P. and Weller, R.O. (2017) The Movers and Shapers in Immune Privilege of the CNS. Nature Immunology, 18, 123-131. [Google Scholar] [CrossRef] [PubMed]
[45] See, A.P., Parker, J.J. and Waziri, A. (2015) The Role of Regulatory T Cells and Microglia in Glioblastoma-Associated Immunosuppression. Journal of Neuro-Oncology, 123, 405-412. [Google Scholar] [CrossRef] [PubMed]
[46] da Fonseca, A.C.C., Matias, D., Garcia, C., Amaral, R., Geraldo, L.H., Freitas, C., et al. (2014) The Impact of Microglial Activation on Blood-Brain Barrier in Brain Diseases. Frontiers in Cellular Neuroscience, 8, Article No. 362. [Google Scholar] [CrossRef] [PubMed]
[47] Aguzzi, A., Barres, B.A. and Bennett, M.L. (2013) Microglia: Scapegoat, Saboteur, or Something Else? Science, 339, 156-161. [Google Scholar] [CrossRef] [PubMed]
[48] Yang, Y.M., Shang, D.S., Zhao, W.D., Fang, W.-G. and Chen, Y.-H. (2013) Microglial TNF-Alpha-Dependent Elevation of MHC Class I Expression on Brain Endothelium Induced by Amyloid-Beta Promotes T Cell Transendothelial Migration. Neurochemical Research, 38, 2295-2304. [Google Scholar] [CrossRef] [PubMed]
[49] Xie, Q., Mittal, S. and Berens, M.E. (2014) Targeting Adaptive Glioblastoma: An Overview of Proliferation and Invasion. Neuro-Oncology, 16, 1575-1584. [Google Scholar] [CrossRef] [PubMed]
[50] Okada, M., Saio, M., Kito, Y., Ohe, N., Yano, H., Yoshimura, S., et al. (2009) Tumor-Associated Macrophage/Microglia Infiltration in Human Gliomas Is Correlated with MCP-3, but Not MCP-1. International Journal of Oncology, 34, 1621-1627. [Google Scholar] [CrossRef] [PubMed]
[51] Lion, E., Smits, E.L., Berneman, Z.N. and Van Tendeloo, V.F. (2012) NK Cells: Key to Success of DC-Based Cancer Vaccines? Oncologist, 17, 1256-1270. [Google Scholar] [CrossRef] [PubMed]
[52] Garofalo, S., D’Alessandro, G., Chece, G., Brau, F., Maggi, L., Rosa, A., et al. (2015) Enriched Environment Reduces Glioma Growth through Immune and Non-Immune Mechanisms in Mice. Nature Communications, 6, Article No. 6623. [Google Scholar] [CrossRef] [PubMed]
[53] Rodriguez-Arellano, J.J., Parpura, V., Zorec, R. and Verkhratsky, A. (2016) Astrocytes in Physiological Aging and Alzheimer’s Disease. Neuroscience, 323, 170-182. [Google Scholar] [CrossRef] [PubMed]
[54] Rothhammer, V., Borucki, D.M., Tjon, E.C., Takenaka, M.C., Chao, C.-C., Ardura-Fabregat, A., et al. (2018) Microglial Control of Astrocytes in Response to Microbial Metabolites. Nature, 557, 724-728. [Google Scholar] [CrossRef] [PubMed]
[55] Gutierrez-Vazquez, C. and Quintana, F.J. (2018) Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity, 48, 19-33. [Google Scholar] [CrossRef] [PubMed]
[56] Rothhammer, V. and Quintana, F.J. (2019) The Aryl Hydrocarbon Receptor: An Environmental Sensor Integrating Immune Responses in Health and Disease. Nature Reviews Immunology, 19, 184-197. [Google Scholar] [CrossRef] [PubMed]
[57] Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritschler, I., Trump, S., et al. (2011) An Endogenous Tumour-Promoting Ligand of the Human Aryl Hydrocarbon Receptor. Nature, 478, 197-203. [Google Scholar] [CrossRef] [PubMed]
[58] Platten, M., Nollen, E., Rohrig, U.F., Fallarino, F. and Opitz, C.A. (2019) Tryptophan Metabolism as a Common Therapeutic Target in Cancer, Neurodegeneration and Beyond. Nature Reviews Drug Discovery, 18, 379-401. [Google Scholar] [CrossRef] [PubMed]
[59] Gramatzki, D., Pantazis, G., Schittenhelm, J., Tabatabai, G., Köhle, C., Wick, W., et al. (2009) Aryl Hydrocarbon Receptor Inhibition Downregulates the TGF-Beta/Smad Pathway in Human Glioblastoma Cells. Oncogene, 28, 2593-2605. [Google Scholar] [CrossRef] [PubMed]
[60] Takenaka, M.C., Gabriely, G., Rothhammer, V., Mascanfroni, I.D., Wheeler, M.A., Chao, C.-C., et al. (2019) Control of Tumor-Associated Macrophages and T Cells in Glioblastoma via AHR and CD39. Nature Neuroscience, 22, 729-740. [Google Scholar] [CrossRef] [PubMed]
[61] Patrizz, A., Dono, A., Zorofchian, S., Hines, G., Takayasu, T., Husein, N., et al. (2020) Glioma and Temozolomide Induced Alterations in Gut Microbiome. Scientific Reports, 10, Article No. 21002. [Google Scholar] [CrossRef] [PubMed]
[62] D’Alessandro, G., Antonangeli, F., Marrocco, F., Porzia, A., Lauro, C., Santoni, A., et al. (2020) Gut Microbiota Alterations Affect Glioma Growth and Innate Immune Cells Involved in Tumor Immunosurveillance in Mice. European Journal of Immunology, 50, 705-711. [Google Scholar] [CrossRef] [PubMed]

为你推荐